S1PR1 and multiple sclerosis: Combined therapy of anti-CD48, anti-lymphocyte function-associated antigen 1 and fingolimod (a sphingosine 1-phosphate receptor modulator for multiple sclerosis treatment) keeps embryonic pig pancreas function in diabetic mice [40].